Jiangsu Hengrui Medicine Co., Ltd.

This study tested whether adding two newer drugs (an immunotherapy and a targeted therapy) to standard chemotherapy could better control advanced non-squamous lung cancer. It involved 48 adults with this specific cancer type who had not yet received chemotherapy for their advance…

This study tested a new inhaled medication, HRG2005, for people with moderate to severe chronic obstructive pulmonary disease (COPD). It aimed to see if the treatment could improve lung function and reduce the frequency of serious symptom flare-ups over nearly a year. The study w…